Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acyclovir in herpes simplex keratitis.

M G Falcon

    The Journal of Infection
    |May 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Herpes simplex keratitis, a leading cause of vision loss, is treated with antivirals. Acyclovir (ACV) shows potential for greater effectiveness in acute infections, iridocyclitis, and post-corneal graft prophylaxis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Postgraduate ophthalmic training: how do we compare?

    Eye (London, England)·2011
    Same author

    An unusual corneal injury.

    The British journal of ophthalmology·1996
    Same author

    Ophthalmoscopic sign of early keratoconus.

    The British journal of ophthalmology·1994
    Same author

    The use of the same size host and donor trephine in penetrating keratoplasty for keratoconus.

    Eye (London, England)·1994
    Same author

    Decentration of the posterior chamber lens implant: the effect of optic size on the incidence of visual aberrations.

    Eye (London, England)·1990
    Same author

    Primary gelatinous drop-like keratopathy.

    The British journal of ophthalmology·1989
    Same journal

    Age-associated impairment of humoral and cellular immune responses to SARS-CoV-2 in a large community cohort with hybrid immunity.

    The Journal of infection·2026
    Same journal

    Genomic characterization of a large-scale chikungunya outbreak in China.

    The Journal of infection·2026
    Same journal

    Convergent neutralizing antibodies to SARS-CoV-2 variants over 2.5 years after BA.5/BF.7 breakthrough infection.

    The Journal of infection·2026
    Same journal

    Multi-strain Clostridioides difficile infection: Increased detection and clinical implications.

    The Journal of infection·2026
    Same journal

    A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment.

    The Journal of infection·2026
    Same journal

    Defining the threshold duration of candidemia associated with poor outcomes: Redefining persistent candidemia.

    The Journal of infection·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Virology
    • Pharmacology

    Background:

    • Herpes simplex keratitis is a primary cause of corneal disease and vision loss globally.
    • The condition necessitates the use of various antiviral medications for treatment.
    • Understanding the clinical efficacy of these antivirals is crucial for patient outcomes.

    Purpose of the Study:

    • To review and assess the clinical value of antiviral drugs used in treating herpes simplex keratitis.
    • To evaluate the comparative effectiveness of different antiviral agents.
    • To specifically examine the role of acyclovir in various stages and complications of the disease.

    Main Methods:

    • Literature review of studies on antiviral drug use for herpes simplex keratitis.
    • Analysis of clinical reports focusing on treatment efficacy.

    Related Experiment Videos

  • Comparative assessment of acyclovir against other antiviral therapies.

    • Main Results:

    • Acyclovir (ACV) demonstrates promising efficacy in treating acute herpes simplex keratitis.
    • Evidence suggests ACV may also be beneficial for herpetic iridocyclitis.
    • ACV shows potential as a prophylactic agent after corneal grafting procedures.

    Conclusions:

    • Acyclovir appears to be a highly effective antiviral for herpes simplex keratitis.
    • Further research may confirm ACV's broad utility across different clinical presentations.
    • Optimizing antiviral therapy is key to preserving vision in patients with herpetic eye disease.